Newsroom
Sorted by: Latest
-
OptionMetrics Exhibiting at Future Alpha NY, Highlighting Role of Options Data in Assessing Alpha Opportunities
NEW YORK--(BUSINESS WIRE)--OptionMetrics, the leading historical options data and analytics provider worldwide, will exhibit at Future Alpha NY March 31 – April 1....
-
Dickey’s Easter Special: $10 Off Catering Packs
DALLAS--(BUSINESS WIRE)--Easter made easy! Dickey’s Barbecue Pit is taking the stress off the table this spring with a limited-time deal on its world-famous catering, so guests can skip the crowds and focus on what matters most: time with loved ones. From now through April 6, guests can enjoy $10 off their group pack orders when they use code EASTER10 online, in restaurant or on Dickey’s mobile app. The pack options at Dickey’s are endless. Open on Easter during normal business hours, Dickey’s...
-
Nebius AI Cloud 3.5 Introduces Serverless AI to Give Developers Frictionless Compute for Real-World AI
AMSTERDAM--(BUSINESS WIRE)--Nebius today unveiled Nebius AI Cloud 3.5, adding significant new capabilities to its full-stack cloud platform that reduce operational friction and enable AI builders to prototype, test, and ship products faster. The introduction of serverless features gives developers the ability to launch workloads almost instantly, eliminating the need for AI teams to spend significant time configuring infrastructure before they can run experiments, train or serve models in produ...
-
Drug Farm Announces U.S. FDA Orphan Drug Designation for DF-003 for the Treatment of ROSAH Syndrome
ALBANY, N.Y. & SHANGHAI--(BUSINESS WIRE)--Drug Farm today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DF-003, the company’s investigational small molecule inhibitor targeting ALPK1, for the treatment of patients with ROSAH syndrome, a rare, genetically driven systemic autoinflammatory disease with significant unmet medical need. ROSAH syndrome (Retinal dystrophy, Optic nerve edema, Splenomegaly, Anhidrosis, and Headache) is a progressi...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 3/26/2026 Issue ¦ NatWest Markets Plc - Series 133 EUR 300,000,000 FRN due September 2027 ISIN Number ¦ XS3196552981 ISIN Reference ¦ 319655298 Issue Nomin EUR ¦ 300000000 Period ¦ 3/30/2026 to 6/30/2026 Payment Date 6/30/2026 Number of Days ¦ 92 Rate ¦ 2.535 Denomination EUR ¦ 100000 ¦ 300000000 ¦ Amount Payable per Denomination ¦ 647.83 ¦ 1943500 ¦ Bank of New York ...
-
Woofie’s Featured on “Military Makeover with Montel” on Lifetime TV, Provides Special Care for Veteran Family’s Beloved Dog
ASHBURN, Va. & LAKE WORTH, Fla.--(BUSINESS WIRE)--Woofie’s will be featured on Military Makeover with Montel on April 2....
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 3/26/2026 Issue ¦ NatWest Markets Plc Series No 113 EUR 200,000,000 FRN Due in April 2026 ISIN Number ¦ XS2697994551 ISIN Reference ¦ 269799455 Issue Nomin EUR ¦ 200000000 Period ¦ 3/30/2026 to 4/28/2026 Payment Date 4/28/2026 Number of Days ¦ 29 Rate ¦ 2.835 Denomination EUR ¦ 1000 ¦ 200000000 ¦ Amount Payable per Denomination ¦ 2.28 ¦ 456750 ¦ Bank of New York Rate...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 3/26/2026 Issue ¦ Barclays Bank PLC - Series 78 EUR 100,000,000 Subordinated FRN due 28 Dec 2040 ISIN Number ¦ XS0122679243 ISIN Reference ¦ 12267924 Issue Nomin EUR ¦ 68000000 Period ¦ 3/30/2026 to 6/29/2026 Payment Date 6/29/2026 Number of Days ¦ 91 Rate ¦ 2.525 Denomination EUR ¦ 1000000 ¦ 68000000 ¦ Amount Payable per Denomination ¦ 6382.64 ¦ 434019.44 ¦ Bank of New Y...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: Banque Saudi Fransi USD 50,000,000.00 MATURING: 04-Oct-2027 ISIN: XS3196100146 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 02-Jan-2026 TO 02-Apr-2026 HAS BEEN FIXED AT 4.47 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 02-Apr-2026 WILL AMOUNT TO: USD 11.16 PER USD 1,000.00 DENOMINATION ...
-
good2grow Celebrates America’s 250th Birthday With Anniversary-edition BIGGER Bottles and Family Trip Giveaway
ATLANTA--(BUSINESS WIRE)--good2grow is launching America's 250th anniversary-edition BIGGER bottles featuring four iconic U.S. national monuments and a nationwide sweepstakes....